J. Goldman & Co’s Gilead Sciences GILD Stock Holding History

J. Goldman & Co’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-40,000	Closed	-$4.91M	–	740
2025 Q4	$4.91M	Hold	40,000	–	–	0.13%	199
2025 Q3	$4.44M	Buy	+40,000	New	+$4.55M	0.11%	212
2025 Q2	–	Sell	-30,000	Closed	-$3.36M	–	528
2025 Q1	$3.36M	Buy	+30,000	New	+$3.1M	0.08%	243
2024 Q1	–	Sell	-27,000	Closed	-$2.19M	–	445
2023 Q4	$2.19M	Sell	27,000 -8,000	-23%	-$623K	0.09%	179
2023 Q3	$2.62M	Buy	+35,000	New	+$2.69M	0.09%	185
2022 Q4	–	Sell	-95,000	Closed	-$5.86M	–	418
2022 Q3	$5.86M	Buy	+95,000	New	+$5.99M	0.28%	106

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

J. Goldman & Co's GILD Position: Q1 2026 in Review

J. Goldman & Co opened a new position in Gilead Sciences (GILD) in Q1 2026: 74,912 shares worth $10.4M. The stake represents 0.3% of the portfolio and ranks #105 among its holdings. This is a return to the name: J. Goldman & Co previously reported a position in GILD as recently as Q3 2025.

J. Goldman & Co first reported a position in GILD in Q1 2017 and has held it in 10 quarters since. The position peaked at $20.9M in Q3 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

J. Goldman & Co held 74,912 shares of Gilead Sciences worth $10.4M as of Q1 2026.
Gilead Sciences was a new J. Goldman & Co position in Q1 2026.
Gilead Sciences made up 0.3% of J. Goldman & Co's portfolio in Q1 2026, its #105 holding.
J. Goldman & Co first reported a position in Gilead Sciences in Q1 2017 and has held it in 10 quarters since.
J. Goldman & Co's Gilead Sciences position peaked at $20.9M in Q3 2025.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on J. Goldman & Co's 13F filing for Q1 2026, filed 15 May 2026.